课题基金 / 基金详情

The radiographic evaluation of choline uptake to the head and neck cancer by mean of PET

The radiographic evaluation of choline uptake to the head and neck cancer by mean of PET
PET对头颈癌胆碱摄取的影像学评价
批准号:
15592002
负责人:
SHOZUSHIMA Masanori
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005

项目摘要

项目成果

SHOZUSHIMA Masanori的其他基金

相似基金

相关文献

中文摘要
翻译
正电子发射断层扫描(PET)与FDG和13 <11>C-标记的胆碱(13 <11>C-胆碱)已被证明是有用的分期和检测癌症。人类癌症中FDG和胆碱摄取增加的背景尚未完全了解。本研究旨在探讨肿瘤细胞摄取~(13)<11>C-胆碱与细胞周期依赖性的关系,以及~(13)C-胆碱PET与~(13<11>)<18>F-脱氧葡萄糖(FDG)PET在头颈部恶性肿瘤中的临床应用价值。<11>HeLa S3细胞在G2/M期C-胆碱摄取较高。此外,FDG摄取在早期S期和G2/M期显著高于G1期。研究<11>了平均SUV与以下参数之间的关系:恶性肿瘤的组织学分级、细胞分化程度、原发病灶的大小和/或局部范围以及肿瘤的细胞密度。平均SUV,标准化摄取值的FDG摄取和放射性核素的管理剂量,体重的病人,不依赖于组织学分级或细胞分化程度,但往往是更大的原发性病变越大。SUV也依赖于细胞密度,肿瘤实质百分比越大,SUV越高,FDG鉴别良恶性病变的临界SUV为3.5。放射<11>化学治疗后残留肿瘤细胞,^C-胆碱显示略优于FDG,尽管两项研究存在一些重叠。C<11>-胆碱在恶性肿瘤中的蓄积速度明显快于FDG。胆碱PET的优点<11>是检查周期短。然而,<11>在唾液腺病变的评估中,13 C-胆碱和FDG都有一定的局限性。
英文摘要
Positron emission tomography (PET) with FDG and ^<11>C-labeled choline (^<11>C-choline) has been shown to be useful in the staging and detection of cancer. The background of the increased uptake of FDG and choline in human cancer is not completely understood. The aim of this research were designed to address investigate the relationship between the ^<11>C-choline uptake and the cell-cycle-dependent of tumor cell, and the clinical value of PET with ^<11>C-choline for malignant head and neck tumors as compared with ^<18>F-fluorodeoxyglucose (FDG) PET.^<11>C-choline uptake was higher in the G2/M phase in HeLa S3 cells. In addition, FDG uptake was significantly higher in the early S phase and G2/M phase compared to the G1 phase. It has been concluded cell cycle dependency is reflected in the uptake of ^<11>C-choline and EDG, seen during PET imaging of tumor tissue.The relationship between the mean SUV and the following parameters was examined : histological grade of malignancy, degree of cell differentiation, size and/or local extent of the primary lesion, and cell density of tumor. The mean SUV, standardized uptake value normalized to FDG-uptake and the administered dose of radionuclide, the body weight of the patient, did not depend on the histological grade or the degree of cell differentiation, but tended to be greater the larger the primary lesion. SUV also depended on cell density ; the greater the percentage of tumor parenchyma, the higher the SUV.The cutoff SUV for differentiating malignant and benign lesions was 3.5 for FDG. ^<11>C-choline showed slightly better than FDG for residual tumor cell after radio-chemo therapy, although some overlap existed on both studies. ^<11>C-choline showed significantly faster accumulation than FDG into Malignant tumors. The advantages of ^<11>C-choline PET were shorter examination period. However, both ^<11>C-choline and FDG have some limitations in the evaluation of salivary gland lesions.
期刊论文(57)
专著(0)
科研奖励(0)
会议论文
口腔領域の悪性腫瘍診断に対するPETの応用
PET在口腔恶性肿瘤诊断中的应用
DOI: --
发表时间: 2004
期刊: 岩医大歯誌 29・3
影响因子: --
作者: [Sakai S, Ohshima M, et al., 小豆島正典]
通讯作者: 小豆島正典
Increased FDG uptake at site of tooth extraction
拔牙部位 FDG 吸收增加
DOI: --
发表时间: 2004
期刊: Jpn J Oral Diag/Oral Med 17・1
影响因子: --
作者: [Shozushima, M.]
通讯作者: M.
The relationship between histopathological findings in oral squamous cell carcinoma and FDG uptake on PET
口腔鳞状细胞癌组织病理学结果与 PET FDG 摄取的关系
DOI: --
发表时间: 2003
期刊: Oral Radiology 19・2
影响因子: --
作者: [Izumisawa, M.]
通讯作者: M.
口腔癌のPET診断
口腔癌的PET诊断
DOI: --
发表时间: 2005
期刊: The journal of dental engineering 152
影响因子: --
作者: [Kawasaki A. et al., Ida N.et al., Ozaki K. et al., Kawasaki A.et al., 小豆島正典]
通讯作者: 小豆島正典
21
    Fundamental and clinical assessment of F-18 Choline as a new cancer tracer for PET
    • 批准号:
      21592398
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2009
    • 负责人:
      SHOZUSHIMA Masanori
    • 依托单位:
    Evaluation of 18F-labeled choline as oncologic PET tracer of oralcancer
    • 批准号:
      18592065
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.46万
    • 财政年份:
      2006
    • 负责人:
      SHOZUSHIMA Masanori
    • 依托单位:
    Diagnosis of oral cancer by ^<11>C-Choline PET
    • 批准号:
      12671837
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      2000
    • 负责人:
      SHOZUSHIMA Masanori
    • 依托单位:
    Lymph node metastasis of oral cancer with 18FDG-PET
    • 批准号:
      09671929
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      1997
    • 负责人:
      SHOZUSHIMA Masanori
    • 依托单位:
    国内基金
    海外基金
    基于高灵敏度PET/CT的碳离子放疗剂量验证与疗效预测研究
    PET分子影像评估肾癌碳酸酐酶9表达异质性及其对靶免联合治疗响应的预测作用与机制研究
    • 批准号:
      JCZRLH202600197
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    基于18F-FAPI-04 PET/CT与增强CT的Suidan评分在卵巢癌减瘤术前评估中的价值比较研究
    • 批准号:
      2026JJ81876
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      戴嘉舜
    • 依托单位:
    间位芳纶(PMIA)短切纤维-涤纶(PET)浆粕复合纸的制备设备研发
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      许红伍
    • 依托单位: